Sildenafil
Product Images NDC 53002-3719

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 53002-3719). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure of sildenafil shown as a 2D molecular diagram depicting its atoms and bonds. The structure highlights the core rings and functional groups typical of sildenafil's chemical composition.*

FDA Label Image

Camber1 (Camber1)

FDA Label Image

Figure-1 (Figure 1)

A forest plot chart showing fold change and 90% confidence intervals for area under the curve (AUC) and maximum concentration (Cmax) of sildenafil when coadministered with various interacting drugs. Recommendations for dose adjustment are listed beside each drug, mostly indicating no dose adjustment except for ritonavir where coadministration is not recommended. The x-axis represents change relative to sildenafil alone, ranging from 0.2 to 13.*

FDA Label Image

Figure-2 (Figure 2)

A bar chart showing fold changes with 90% confidence intervals for various drugs interacting with sildenafil, including Acenocoumarol, Aspirin, Atorvastatin, Bosentan, Doxazosin (three doses), Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, Saquinavir, and Tolbutamide. The chart compares changes in parameters like INR, AUC, Cmax, and bleeding time relative to each interacting drug alone. Recommendations for dose adjustments or coadministration are noted alongside each drug.*

FDA Label Image

Figure-3 (Figure 3)

A line chart illustrating change from baseline in meters over 12 weeks of study for four groups: Placebo, Sildenafil 20 mg TID, Sildenafil 40 mg TID, and Sildenafil 80 mg TID. The x-axis shows study weeks 4, 8, and 12, and the y-axis shows change from baseline with error bars around each data point.*

FDA Label Image

Figure-4 (Figure 4)

A clinical research chart showing the placebo-corrected change in 6-minute walk distance with Sildenafil 20 mg TID. The chart includes subgroups by baseline walk distance, etiology, PH functional class, gender, age, mean PAP, and PVRI, with sample sizes and horizontal error bars indicating variability.*

FDA Label Image

Figure-5 (Figure 5)

A Kaplan-Meier survival curve chart comparing the percentage of subjects without a clinically worsening event over time, from day 0 to 112 after randomization. Two groups are shown: a placebo group indicated by a solid line and a sildenafil group indicated by a dashed line, with the sildenafil group maintaining a higher percentage without worsening over time.*

FDA Label Image

Figure-6 (Figure 6)

A chart depicting the percent change in VO2 peak across different treatment groups, including placebo, low dose, medium dose, high dose, and combined dose. Each group shows a mean value with error bars representing variability, with sample sizes ranging from 24 to 77 subjects per group, illustrating the effect of different dosing levels on VO2 peak change.*

FDA Label Image

Label Image (Lbl530023719)

Sildenafil 20mg tablets packaging label from RPK Pharmaceuticals, Inc. The label indicates a bottle containing 30 tablets with directions to take as directed. It includes space for clinic and patient information, along with barcodes and regulatory data such as lot number, expiration date, and NDC code 53002-3719.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.